Trzaska; Scott

Patent Applications and Registrations

Patent applications and USPTO patent grants for Trzaska; Scott.The latest application filed is for "methods of treating acute kidney injury".

Company Profile

1.4.10

Trzaska; Scott - Raritan NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Acute Kidney Injury App 20210283116 - Lagu; Bharat ; et al.	2021-09-16
Polymorphs Of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-- 1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic Acid App 20210251964 - Lawton; Graham ; et al.	2021-08-19
Crystalline And Salt Forms Of Ppar Agonist Compounds App 20210171494 - Lagu; Bharat ; et al.	2021-06-10
Crystalline and salt forms of PPAR agonist compounds Grant 10,927,094 - Lagu , et al. February 23, 2	2021-02-23
Crystalline And Salt Forms Of Ppar Agonist Compounds App 20200181108 - Lagu; Bharat ; et al.	2020-06-11
Crystalline forms of a BACE inhibitor, compositions, and their use Grant 10,035,796 - Kazakevich , et al. July 31, 2	2018-07-31
Novel Crystalline Forms Of A Bace Inhibitor, Compositions, And Their Use App 20170233383 - Trzaska; Scott ; et al.	2017-08-17
Novel Crystalline Forms Of A Bace Inhibitor, Compositions, And Their Use App 20170226098 - Kazakevich; Irina ; et al.	2017-08-10
Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin Grant 9,604,971 - Trzaska , et al. March 28, 2	2017-03-28
Co-crystal Of The Par-1 Receptor Antagonists Vorapaxar And Asprin App 20160159779 - Trzaska; Scott ; et al.	2016-06-09
Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methox- y-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore Grant 7,956,189 - Chen , et al. June 7, 2	2011-06-07
Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methox- y-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore App 20080108818 - Chen; Xiaoming ; et al.	2008-05-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.